The Obesity Explosion:
How Did We Get Here and Where Are We At?
Donald D. Hensrud, M.D., M.P.H.
Chair, Division of Preventive, Occupational, and Aerospace Medicine
Associate Professor of Preventive Medicine and Nutrition
©2012 MFMER | slide-2
Disclosure
Relevant financial relationships
• None
Off label usage
• None
©2012 MFMER | slide-3
Learning Objective
• Describe background information on obesity including
• Classification
• Prevalence and trends
• Contributing factors
• Health complications
• Treatment
• Diet
• Physical activity
• Behavior change
• Medications
• Surgery
©2012 MFMER | slide-4
©2011 MFMER |
Obesity
Obesity (def) - an excess of body fat resulting in
adverse health effects
©2012 MFMER | slide-6
©2011 MFMER | 3142097-6
Obesity,
Risk Assessment and Classification
Adapted from Clinical guidelines on Obesity. National Heart, Lung, and Blood Institute Web site.
Available at: http://www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm
Disease Risk Relative to Normal Weight and Waist Circumference
Men 40 in Men >40in Category BMI, kg/m
2Women 35 in Women >35 in
Underweight <18.5 – –
Normal* 18.5-24.9 – –
Overweight 25.0-29.99 Increased High
Obesity 30.0-39.9 High Very high
35.0-39.9 Very high Very high Extreme obesity 40 Extremely high Extremely high
* An increased waist circumference can denote increased disease risk even
in persons of normal weight
Obesity Trends Among U.S. Adults BRFSS, 1990
No Data <10% 10%–14%
©2012 MFMER | slide-8
Obesity Trends Among U.S. Adults BRFSS, 2000
No Data <10% 10%–14 15%–19% ≥20%
Obesity Trends Among U.S. Adults BRFSS, 2010
No Data <10% 10%–14 15%–19% 20%–24% 25%–29% ≥30%
©2012 MFMER | slide-10
Global Obesity
• Obesity around the world has doubled since 1980
• Overweight and obesity are linked to more deaths worldwide than underweight
• Overweight and obesity are the fifth leading risk for global deaths
©2011 MFME
R | 31420
97-10
©2012 MFMER | slide-11
©2011 MFME
R | 31420
©2012 MFMER | slide-12
©2011 MFMER | 3142097-12
Prevalence of Overweight and Obesity, NHANES 2009-2010
All (%) Men (%) Women (%)
Overweight 68.8 73.9 63.7
Obese 35.7 35.5 35.8
Extreme obese 6.3 4.4 8.1
JAMA 2012;307:491
©2011 MFMER |
Prevalence of Overweight and Obesity, NHANES 2009-2010
JAMA 2012;307:491 All White Black Hispanic White Black Hispanic
Overweight
33.1 37.8 31.1 44.7 27.3 23.6 34.3 BMI 25-29.9
Obese
35.7 36.2 38.8 37.0 32.2 58.5 41.4
BMI 30
Extreme obese
6.3 4.2 7.4 4.1 7.1 17.8 6.0 BMI 40
Men Women
©2012 MFMER | slide-14
©2011 MFMER | 3142097-14
Obesity, Health Complications
• Type 2 Diabetes Mellitus
• Hypertension
• Dyslipidemia
• High triglycerides
• Low HDL cholesterol
• Small, dense LDL cholesterol
• Coronary artery disease
• Stroke
• Overall mortality
©2011 MFMER |
Obesity, Health Complications
• Most cancers
• Respiratory diseases
• Obstructive sleep apnea
• Restrictive lung disease
• Obesity hypoventilation syndrome
• Asthma
• Osteoarthritis
• Cholelithiasis
• Gastroesophageal reflux disease (GERD)
• Nonalcoholic fatty liver disease (NAFLD)
©2012 MFMER | slide-16
©2011 MFMER | 3142097-16
Obesity, Health Complications
• Gynecologic abnormalities
• Abnormal menses
• Infertility
• Polycystic ovarian syndrome
• Venous stasis
• Skin problems
• Intertrigo
• Cellulitis
• Increased risk of complications during surgery
or pregnancy
©2011 MFMER |
Societal Cost of Overweight and Obesity
Data from Dor A et al:George Wash Univ, 2010 and
1Health Affairs 2009;28:w822; 2Int J Obes 2005;29:334
3Obes 2008;16:2323; 4National Bureau of Economic Research, 2010
Study Year Overweight Obesity
Finkelstein 1 1998 76.5
Arterburn 2 2000 24.8 55.9
Wang 3 2000 27.4-29.7 76.6-87.7
Finkelstein 1 2008 151.7 (147)
Cawley 4 2010 168.4
Cost in $ billions/yr*
*2009 dollars
©2012 MFMER | slide-18
©2011 MFMER | 3142097-18
Individual Yearly Costs of Obesity
Men, $ Women, $
Overweight 432 524
Obese 2,646 4,879
Obese + VLL 6,518 8,365
(value of life lost)
Dor A et al: George Wash Univ, 2010
• Direct and indirect costs (disability, decreased productivity, absenteeism, etc.)
• Direct medical costs largest % for overweight
• Lost wages largest % for obese women
©2011 MFMER |
Obesity Costs, Who Pays?
• Medicare and Medicaid pay about half of all costs 1
• Business paid an estimated $12.7 billion in 1994 (5% of total medical care costs) 2
• Cost of obesity among full-time employees estimated to be $73 billion in 2006-2008 in a recent study 3
1Health Affairs 2009;28:w822; 2Am J Health Prom 1998;13:120
3J Occup Environ Med 2010;52:971
©2012 MFMER | slide-20
Pathogenesis of Obesity
• Genetics vs. environment
• 30% - 40% of variance related to genetics
• Environment
• Diet/energy intake
• Physical activity
• Exercise
• Daily activities
• Individual factors
©2011 MFMER |
©2012 MFMER | slide-22
©2011 MFMER | 3142097-22
©2012 MFMER | slide-23
Management Plan
• Diet
• Physical activity
• Exercise
• Daily activities
• Behavior change
• Medications
• Surgery
©2011 MFME
R | 31420
*Use the assessment and history to tailor the plan
©2012 MFMER | slide-24
Individualized Weight Loss
• Hundreds of different influences
• Diet
• Physical activity
• Behavior
• Everyone has different obstacles
• Everyone’s plan should have tailored strategies
• Mayo Clinic Diet – Action Guide
©2011 MFME
R | 31420
97-24
©2012 MFMER | slide-25
©2011 MFME
R | 31420
©2012 MFMER | slide-26
Weight Loss, Diet
• Diet
• There is no one best diet
• Tailor the dietary program to the individual
• Minimum dietary standards
• Sound scientific rationale
• Safe and nutritionally adequate
• Practical and effective long-term
©2012 MFMER | slide-27
©2011 MFME
R | 31420
©2012 MFMER | slide-28
Dietary Therapy, AHA/ACC/TOS Recommendations
• Calorie deficit of 500 - 750 kcal/day
• Promotes weight loss of 1 - 2 pounds/week
• Low CD
• 1,200 - 1,500 kcal/day for women
• 1,500 - 1,800 kcal/day for men
• Choose a diet based on patient preferences
• 3-5% weight loss leads to clinical benefit
Weight Loss, Different Macronutrient Composition
• 811 overweight adults, 2 years
• Group and individual instructions
• 4 reduced calorie diets:
NEJM 2009;360:859
Fat Protein Carbohydrates
20 15 65
20 25 55
40 15 45
40 25 35
©2012 MFMER | slide-30
Weight Loss, Different Macronutrient Composition
-7 -6 -5 -4 -3 -2 -1 0
0 6 12 18 24
W ei ght lo ss (k g)
Months
NEJM 2009;360:859
65/15/20%
55/25/20%
45/15/40%
35/25/40%
©2012 MFMER | slide-31
Weight Loss, Different Macronutrient Composition
• 80% completed 2 years
• Most weight loss occurred by 6 months (6 kg)
• No significant differences among groups in weight loss or cardiovascular risk factors
• Mean weight loss among all participants 4 kg at 2 years
• Attendance at group sessions was strongly associated with weight loss
©2011 MFME
R | 31420
©2012 MFMER | slide-32
Methods of Calorie Restriction
• Counting calories
Discrepancy Between Reported and Actual Energy Intake and Expenditure
0 500 1,000 1,500 2,000 2,500 3,000
Reported Actual Reported Actual
*
*
Lichtman et al: N Engl J Med 1992;327:1893
kc al /d
Energy Intake Energy Expenditure
*P<0.05 vs reported
©2012 MFMER | slide-34
Methods of Calorie Restriction
• Counting calories
• Counting fat grams
• Point system
• Exchange system
• Moderation of portion size, types of foods, etc.
• Very-low calorie diets
• Liquid meal replacements
• Energy density
©2012 MFMER | slide-36
©2012 MFMER | slide-38
©2012 MFMER | slide-40
©2012 MFMER | slide-42
Fruits & Vegetables and Weight Gain
• 74,000 females followed for 12 years in the Nurses’ Health Study
• Those with the largest increase in intake of
fruits and vegetables had a 24% decreased risk of becoming obese
Int J Obes 2004;28:269
©2012 MFMER | slide-44
Dietary Changes and Weight Changes
Dietary Change Weight Change, lb
Potato chips 1.69
Potatoes 1.28
Sugar-sweetened drinks 1.00
Unprocessed red meat 0.95
Processed meat 0.93
Vegetables -0.22
Whole grains -0.37
Fruits -0.49
Nuts -0.57
Yogurt -0.82
NEJM 2011;364:25
Mayo Clinic Healthy Weight Pyramid
©2012 MFMER | slide-46
Determinants of What We Eat
Objective
• Evidence from scientific studies
Subjective
• Cost
• Convenience
• Time
• Food availability
• What we grew up eating
• Taste preferences
• Marketing
• Ethnicity
• Social influences
©2012 MFMER | slide-47
Healthful Dietary Change
• Attitude
• People underestimate their ability to change
• Eating healthy vs. eating well
• Lifestyle
• Practical
• Palatable
• Promote satiety
• Low in calories
• Healthy
©2011 MFME
R | 31420
©2012 MFMER | slide-48
©2012 MFMER | slide-50
Physical Activity, Recommendations
• 150 min/week of moderate-intensity physical activity (e.g., brisk walking)
• 75 min/week of vigorous intensity physical activity (e.g., jogging or running)
• To effectively lose or maintain weight, may need 300 min/week of moderate-intensity physical
activity
©2011 MFME
R | 31420
97-50
http://www.cdc.gov/physicalactivity/everyone/guidelines/adults.html
©2012 MFMER | slide-51
Exercise
• Exercise vs daily activities
• Pick an exercise that:
• Is enjoyable
• Can be performed regularly
• Can be continued indefinitely
• Frequency, duration, intensity
©2011 MFME
R | 31420
©2012 MFMER | slide-52
Obesity, Fitness, and Mortality
©2011 MFME
R | 31420
97-52
Lee CD: AM J Clin Nutr 1999; 69:373 0.0
0.5 1.0 1.5 2.0 2.5
Lean Normal Obese
Adj us ted RR
Body Fat (%)
Fit Unfit
(<16.7) (>25)
©2012 MFMER | slide-53
Daily Activities
• Human nature - conserve energy and decrease activity
• Years ago – survival advantage
• Now – shortens survival
• Different mindset – look for opportunities to obtain increased activity
• Burn calories
• Feel better
• Improve health
©2011 MFME
R | 31420
©2012 MFMER | slide-54
Daily Activities
• Take the long way around
• Choose outdoor vacations/activities
• Avoid using children to do tasks (don’t let them get all the benefits)
• Walk whenever you can
• Stairs, park farther away
• Around the office
• Airports (don’t use the moving walkway)
• Consider a pedometer
©2011 MFME
R | 31420
97-54
©2012 MFMER | slide-55
©2011 MFME
R | 31420
Television Time and Health
• Each 2 hours of TV time increases the risk of:
• Type 2 diabetes by 20%
• Cardiovascular disease by 15%
• All-cause mortality by 13%
• Studies reported similar results after controlling for exercise
©2011 MFMER | 3135329-55
JAMA 2011;305:2448
©2012 MFMER | slide-56
Weight Loss Strategies
• Determine general goals (health, weight, etc.)
• Determine obstacles and tailor the approach to address obstacles
• Have specific plans, and plan ahead
• Provide suggestions and motivation
• Provide educational information (online, print, etc.)
• Consider commercial programs for
partnering/follow-up (weight, coaching)
• Individualize the plan
©2012 MFMER | slide-58
Weight Loss Strategies
• Diet tracking (e.g., sparkpeople.com, myfitnesspal.com, Livestrong.com)
• Physical activity tracking (e.g., Fitbit, Omron, Gruve)
• Focus on the process (lifestyle change) and health, not the outcome (pounds)
• Use process goals - SMART
• The process can be enjoyable!
• Expect lapses – problem solving
Weight Loss, Systematic Strategies
• Stepped-care approach
• Lifestyle counseling in primary care
• Remote treatment
©2012 MFMER | slide-60
Stepped-Care Approach for Obesity
• 363 overweight and obese adults
• 18 months
• 72% follow-up
• Randomized to standard behavior therapy vs.
stepped-care
• Counseling frequency, type, and weight loss strategies modified every 3 months with
increasing intensity if goals are not made
• Weight loss: -7.5 kg std. vs. -6.3 kg stepped-care
• Cost: $1,357 std. vs. $785 stepped-care
JAMA 2012:307:2617
Lifestyle Counseling in Primary Care Treatment of Obesity
• 390 obese adults
• 2 years
• 86% follow-up
• Randomized to:
• Usual care – quarterly visits and education
• Brief lifestyle counseling with coaches
• Enhanced lifestyle counseling (meal replacements or medications)
• Weight loss: -1.7 kg, -2.9 kg, -4.6 kg, respectively
NEJM 2011;365:1969
©2012 MFMER | slide-62
In-Person vs Remote Treatment of Obesity
• 415 obese adults
• 2 years, 95% follow-up
• Randomized to in-person vs. remote intervention vs. control
• Intervention
• Coaches (in-person vs telephone)
• Web-based support
• Weight loss: -0.8 kg control, -4.6 kg remote, -5.1 in-person
NEJM 2011;365:1959
©2012 MFMER | slide-64
©2012 MFMER | slide-65
Weight Loss Medications
• Orlistat
• Phentermine
• Qsymia (phentermine/topiramate)
• Belviq (lorcaserin)
©2011 MFME
R | 31420
©2012 MFMER | slide-66
Obesity, Bariatric Surgery
• Indications
• BMI >40
• BMI >35 when complications present
• Roux-en-Y gastric bypass procedure of choice over vertical banded gastroplasty
• Efficacy - >50% excess weight lost after one
year (usually >100 lb) and most weight loss
maintained
Bariatric Surgery
Standard Roux-en-Y Gastric Bypass
©2012 MFMER | slide-68
Obesity, Bariatric Surgery
• Complications
• dumping syndrome staple line disruption
• headaches small bowel obstruction
• stomal ulcer dehydration
• iron deficiency vomiting
• vitamin B12 deficiency
• diarrhea > constipation
• hair loss (temporary)
• stenosis of gastrojejunal anastomosis
Treatment of Obesity, Success
Weight
• Weight loss
• Long-term weight maintenance
• Prevention of weight gain
• Inches lost
• Improvement in body composition Health
• Improvement in comorbidities of obesity
• Improved health habits
• Improvement in quality of life
©2012 MFMER | slide-70